What Happened?
San Diego, -based Kinnate Resigned Maryam Abdul-Kareem as Deputy General Counsel
About the Company
Kinnate Biopharma Inc. is a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer. The company is developing medicines for known oncogenic drivers where there are no approved targeted drugs and to overcome the limitations of marketed cancer therapies, such non-responsiveness or acquired and intrinsic resistance. Kinnate has two lead clinical programs being studied in solid tumors with RAF, NRAS and FGFR-driven alterations, and is rapidly progressing a pipeline of additional small molecule drug candidates as part of the Kinnate Discovery Engine.
About the Person
Maryam Abdul-Kareem is General Counsel at Arcellx. Previously, Maryam held various senior legal leadership roles in the industry.
Info Source
News
Short Profile